stockrowCytokinetics, Incorporated
CYTK Healthcare Biotechnology
Cytokinetics, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $88.0 million, up 376.6% from fiscal 2024.
- Revenue
- +2,356.5%
- EPS
- +46.3%
- Free cash flow
- −6.73%
- Total debt
- −83.9%
Quarter to September 2026, against a year earlier
Follow CYTK
Alert me
Cytokinetics, Incorporated (CYTK) Revenue growth
Cytokinetics, Incorporated's revenue growth over the twelve months to 30 September 2026 was 29.9%, down 346.7 percentage points from fiscal 2025 (376.6%). Over the past ten years it has ranged from −92.0% (fiscal 2023) to 376.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 6.26% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 376.6% | 231.22 |
| FY2024 | 145.3% | 237.38 |
| FY2023 | −92.0% | (126.34) |
| FY2022 | 34.3% | 8.15 |
| FY2021 | 26.2% | (81.64) |
| FY2020 | 107.8% | 122.50 |
| FY2019 | −14.7% | (150.35) |
| FY2018 | 135.6% | 223.08 |
| FY2017 | −87.4% | (358.74) |
| FY2016 | 271.3% | 310.25 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 2,356.5% | 2,413.59 |
| Jun 2026 | −57.1% | (1,182.91) |
| Mar 2026 | 1,125.8% | 1,120.89 |
| Dec 2025 | 4.89% | (313.25) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| MDGL Madrigal Pharmaceuticals, Inc. compare | 92.8% |
| CAI Caris Life Sciences,�Inc. compare | 68.8% |
| PTGX Protagonist Therapeutics, Inc. compare | 34.8% |
| CORT Corcept Therapeutics Incorporated compare | 30.0% |
| CYTK Cytokinetics, Incorporated | 29.9% |
| KRYS Krystal Biotech, Inc. compare | 26.0% |
| TWST Twist Bioscience Corporation compare | 19.2% |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | 16.1% |
| SYRE Spyre Therapeutics, Inc. compare | −81.8% |
| Biotechnology industry median | 6.26% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on CYTK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement